Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

231.54 +8.38 (+3.76%)
Official Closing Price Updated: 6:30 PM EDT, Sep 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,187,116
Open 223.06
Bid (Size) 228.57 (1)
Ask (Size) 230.99 (3)
Prev. Close 223.16
Today's Range 222.56 - 232.35
52wk Range 163.81 - 232.35
Shares Outstanding N/A
Dividend Yield 2.83%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
U.S. Drug Pricing Reforms Send Ripples Across Global Healthcare Sector
The global healthcare sector is currently navigating a period of profound transformation, driven by aggressive regulatory changes emanating from the United States. As of late September 2025, a series... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government

Performance

YTD
+29.0%
+29.0%
1 Month
+9.3%
+9.3%
3 Month
+24.7%
+24.7%
6 Month
+10.5%
+10.5%
1 Year
+17.2%
+17.2%

More News

Read More
A Closer Look at AbbVie's Options Market Dynamics
Via Benzinga
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
Via MarketMinute
Topics Government
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Via MarketMinute
Topics Economy Government World Trade
AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever
Via The Motley Fool
Topics ETFs Stocks
Here's How Much $100 Invested In AbbVie 5 Years Ago Would Be Worth Today
Via Benzinga
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
Via Benzinga
Topics ETFs
1 Top ETF I Wouldn't Hesitate to Invest $1,000 Into Right Now
Via The Motley Fool
Topics ETFs Stocks
Why the Schwab U.S. Dividend Equity ETF Could Be a Top Choice for Dividend Investors in 2025
Via The Motley Fool
Topics ETFs Stocks
5 Dividend Powerhouses to Buy and Never Sell
Via The Motley Fool
Topics Intellectual Property
Major Insider Sale Casts Shadow on LENZ Therapeutics' Valuation
Via MarketMinute
Topics Artificial Intelligence
NEXGEL Inc. Equity Warrants: A High-Stakes Bet on Future Profitability Amidst Rapid Growth
Via MarketMinute
Topics Intellectual Property
Decoding AbbVie's Options Activity: What's the Big Picture?
Via Benzinga
Pharma Tariffs Back In Spotlight On New Trump Threat
Via Investor's Business Daily
Topics ETFs Government World Trade
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Via Benzinga
Topics Government World Trade
3 Top Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Topics Intellectual Property
Where Will AbbVie Be in 5 Years?
Via The Motley Fool
Topics Earnings Economy Government
Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies
Via Benzinga
STRATA Skin Sciences Soars as Landmark Study Reveals Superior Vitiligo Treatment Efficacy
Via MarketMinute
Topics Intellectual Property
The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning
Via Benzinga
1 Top Dividend Stock to Buy and Hold Forever
Via The Motley Fool
Topics Economy Initial Public Offering Intellectual Property
Inflation's Lingering Shadow: Long-Term Expectations Rise Amidst Fed Rate Cuts
Via MarketMinute
Topics Bonds ETFs Economy
Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 231.54
When was AbbVie last traded?
The last trade of AbbVie was at 09/30/25 06:30 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.